Amanote Research
Register
Sign In
A3.2 a CD4+ T-Cell Gene Expression Signature Predicts Drug Survival on Methotrexate Monotherapy in Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases
- United Kingdom
doi 10.1136/annrheumdis-2013-203216.2
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Date
February 25, 2013
Authors
AG Pratt
PM Brown
SJ Cockell
G Wilson
JD Isaacs
Publisher
BMJ
Related search
IgG Fc Galactosylation Predicts Response to Methotrexate in Early Rheumatoid Arthritis
Arthritis Research & Therapy
Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis
RMD Open
Rheumatology
Allergy
Immunology
Gene‑expression Signature Predicts Survival Benefit From Postoperative Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
Oncology Letters
Cancer Research
Oncology
T-Cell Aging in Rheumatoid Arthritis
Current Opinion in Rheumatology
Rheumatology
Gene Expression Profiling in Rheumatoid Arthritis
P141 Differential DNA Methylation in Peripheral naÏve CD4+T-cells in Early Rheumatoid Arthritis Patients
THU0003 CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Untreated Early Arthritis: Implications for Causal Gene Identification?
A Five-Gene Signature Predicts Overall Survival of Patients With Papillary Renal Cell Carcinoma
PLoS ONE
Multidisciplinary
Cyclosporin a Monotherapy Versus Cyclosporin a and Methotrexate Combination Therapy in Patients With Early Rheumatoid Arthritis: A Double Blind Randomised Placebo Controlled Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
